CHINA MEDICAL SYSTEM HLDGS LTD
(SGX: 8A8)

China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.

2.230 CD

+0.080 (+3.72%)
价格区间 2.150 - 2.230   (3.72%)
开盘 2.150
昨收 2.150
2.150
买盘 ('000) 9.9
-
卖盘 ('000) -
成交量 ('000) 5.1
成交额 11,365
注释 CD
数据延迟。最后一次更新02 Apr 2026 11:59.
数据提供商

未来大事

Dividend

除权日 28 April 2026
登记日 29 April 2026
支付日 07 May 2026
DIVIDEND : CNY 0.1366

AGM

会议日期 23 April 2026
会议时间 10:00 AM
10.00 A.M. AT 8/F, OASIS ROOM, RENAISSANCE HARBOUR VIEW HOTEL HONG KONG, 1 HARBOUR ROAD, WANCHAI, HONG KONG.
数据由SGX提供支持。
查看所有活动


Loading Chart...

Please login to view stock data and analysis